Completed PHASE4 INTERVENTIONAL NCT00168467

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Sponsor: Baker Heart Research Institute

Interventions Ramipril

Updated 5 times since 2017 Last updated: Jan 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00168467, this PHASE4 trial focuses on Peripheral Arterial Disease and remains completed. Sponsored by Baker Heart Research Institute, it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baker Heart Research Institute

Data source: Baker Heart Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia